GT Medical Technologies

GT Medical Technologies

Private
Tempe, ArizonaHealthcare & Life Scienceshttps://www.gtmedtech.com

Last Round

Series D

Jul 15, 2025

Total Funding Raised

$159M

Company Overview

GT Medical Technologies is a medical technology company that develops innovative therapeutic solutions to address the challenges of treating recurrent brain tumors, utilizing a bioresorbable collagen tile and a uniform radiation source to enhance patient outcomes and quality of life.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

GammaTile Therapybrain tumor treatmentimplantable radiation therapybrachytherapysurgically targeted radiation therapySTRTintracavitary brachytherapyglioblastoma treatmentradiation seedbrain brachytherapymedical devicetumor recurrenceCesium-131brain metastasesaggressive meningiomasradiation oncologyneurosurgery device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GT Medical Technologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GT Medical Technologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJul 15, 2025
DebtSep 12, 2024
Series CMar 23, 2023
Series BNov 23, 2020
Series AJan 31, 2019

Key People

Founding team and executive leadership

Per Langoe

Chief Executive Officer

Executive Team

David Brachman

Chief Technology Officer

Executive Team

Sandeep Yadav

Chief Financial Officer

Executive Team

Ole Mikkelsen

Chief Operating Officer

Executive Team

GT Medical Technologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2025

    $53M round completed.

  • Apr 9, 2025

    Announced the GammaTile Center of Excellence Program.

GT Medical Technologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GT Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GT Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersTempe, Arizona
Employee Range101
Year Founded2017
Last FundingJul 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.